Obesity as a disease state: a new paradigm for diagnosis and treatment (Q47439042)

16 January 2018

title

Obesity as a disease state: a new paradigm for diagnosis and treatment (English)

1 reference

16 January 2018

0 references

Louis J Aronne

1

1 reference

16 January 2018

Donald S Nelinson

series ordinal

2

1 reference

16 January 2018

Joseph L Lillo

series ordinal

3

1 reference

16 January 2018

publication date

1 January 2009

1 reference

16 January 2018

published in

Clinical cornerstone

1 reference

16 January 2018

volume

9

1 reference

16 January 2018

issue

4

1 reference

16 January 2018

page(s)

9-25; discussion 26-9

1 reference

16 January 2018

Medical Consequences of Obesity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The epidemic of obesity and changes in food intake: the Fluoride Hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Decline in physical activity in black girls and white girls during adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The Spread of Obesity in a Large Social Network over 32 Years

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Assessment of the obese patient

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Obesity and diabetes in vulnerable populations: reflection on proximal and distal causes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Fetal growth and adult diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Human obesity: an evolutionary approach to understanding our bulging waistline

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

A Nutrition Paradox — Underweight and Obesity in Developing Countries

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The nutrition transition and its health implications in lower-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The Nutrition Transition: New Trends in the Global Diet

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The importance of treating cardiometabolic risk factors in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Treatment of obesity: need to focus on high risk abdominally obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Abdominal adiposity and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Actual Causes of Death in the United States, 2000

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Years of life lost due to obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Annual Deaths Attributable to Obesity in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The effect of age on the association between body-mass index and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Body Weight and Mortality among Women

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Minireview: Adiposity, Inflammation, and Atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The role of adiposity as a determinant of an inflammatory milieu.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Obesity and the role of adipose tissue in inflammation and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adipokines: molecular links between obesity and atheroslcerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Plasminogen activator inhibitor-1 and haemostasis in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adipokines: inflammation and the pleiotropic role of white adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Leptin receptor signaling and action in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Inflammatory mechanisms in the regulation of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Does leptin cause vascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Behavioral therapy for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Behavioral treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Treatment modalities of obesity: what fits whom?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Medicare's search for effective obesity treatments: diets are not the answer

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Randomized trial of lifestyle modification and pharmacotherapy for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Long-term mortality after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2809%2980002-1

7 January 2021

10.1016/S1098-3597(09)80002-1

Identifiers

DOI

1 reference

16 January 2018

PubMed ID

19789061

1 reference

16 January 2018